Author

Julie Zhao

Boston Children's HospitalPrimary ORCID profile (0000-0001-8729-8986 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Julie ZhaoiD1 paper · The Graduate Center, CUNY

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alan S. Kopin· 1 shared Biyao ZhangiD· 1 shared Bruna Lenfers TurnesiD· 1 shared Darius Ebrahimi‐FakhariiD· 1 shared Darred Surin· 1 shared Emma Cropper· 1 shared Francesco VillaiD· 1 shared Leo Mejia· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alan S. Kopin

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Preclinical validation of AAV9-TECPR2 gene therapy in a novel knock-in model of TECPR2-related disorder

Bruna Lenfers Turnes, Peter Casey-Caplan, Leo Mejia, Tiffany Berry, Julie Zhao, Francesco Villa, Emma Cropper, Maryam Arab, Biyao Zhang, Darred Surin, Darius Ebrahimi‐Fakhari, Silmara de Lima, Alan S. Kopin, Nick J Andrews, Nathaniel Hodgson, Michela Fagiolini

This study develops a TECPR2 knock-in mouse model and shows that AAV9-mediated gene therapy improves mechanosensory function, gait, and startle responses in neonatal mice with TECPR2 deficiency.

bioRxiv · Mar 25, 2026 · PreprintNeuroscience